NewGenIvf Group Ltd: A Quick Guide for Investors

I wrote this guide to help you understand NewGenIvf Group Ltd. My goal is to cut through the corporate jargon so you can decide if this company fits your investment goals.

1. What does this company do?

NewGenIvf began as a fertility clinic in Thailand, offering IVF, egg freezing, and genetic testing. Today, the company is undergoing a significant transformation. They are moving away from fertility services to become a diversified conglomerate. Their new focus includes real estate development in Southeast Asia, digital asset management—specifically staking Solana (SOL) tokens—and mineral mining. This shift moves the company away from its medical roots into capital-intensive, speculative industries.

2. Financial health: A major warning sign

The company is in a fragile financial position. By the end of 2025, they held approximately $758,621 in cash. This is a limited runway for a firm attempting to scale operations across three unrelated industries.

They rely on "convertible notes"—loans that lenders can turn into company stock at a discount—and a credit line to maintain operations. They have borrowed roughly $15.55 million to cover daily costs and overhead. Because the fertility business does not generate consistent profit, the company frequently issues new shares to pay off debt and fund their new ventures.

3. Why this matters to you

When a company creates new shares to pay off debt, it dilutes your ownership percentage. Think of it like a pizza: if the company keeps cutting the pizza into more slices, your individual slice gets smaller. This is why the company has performed six reverse stock splits in just over a year. They took this step to keep their share price above the $1.00 minimum required by the stock exchange, as their share price has faced consistent downward pressure.

4. Major risks: The "Going Concern" warning

The company’s own annual report includes a "going concern" warning. This signals that management has identified significant doubt regarding the company's ability to pay its bills over the next 12 months.

• Operational Transition: They are entering mining and crypto without a long-standing track record or specialized infrastructure in these sectors.
• Market Competition: Large hospital networks and private equity firms dominate the fertility market, and NewGenIvf faces challenges in maintaining scale against these competitors.
• Volatility: By moving into crypto and real estate, the company is exposed to extreme market swings. Their digital assets are tied to the volatile Solana blockchain, while their real estate projects are sensitive to interest rate hikes and broader economic downturns.

5. The Bottom Line

NewGenIvf is a high-risk turnaround play. They are attempting to reinvent their business model while spending capital at a rate that exceeds their current revenue. For a retail investor, this presents a significant risk of losing your entire investment. They are betting the company’s survival on industries where they lack a proven history of success.

My take: This company is in survival mode. Until they can demonstrate a stable, profitable business model that generates its own cash—rather than relying on selling more shares to pay creditors—it remains a highly speculative and dangerous investment.